Cutaneous metastases of breast cancer during adjuvant chemotherapy correlates with increasing CD44(+)/CD24(-) and ALDH-1 expression: a case report and literature review

乳腺癌辅助化疗期间皮肤转移与CD44(+)/CD24(-)和ALDH-1表达增加相关:病例报告及文献综述

阅读:1

Abstract

Cancer stem cells (CSCs) within a tumor are scarce and self-sustaining and they have the abilities for self-renewal and the potential of giving rise to diverse types of cells that compose the tumor. These cells are suggested to be associated with therapeutic failure, and therefore they remain as an important issue in this regard. We report the cases of two breast cancer patients diagnosed with rapid cutaneous metastases during adjuvant cytotoxic chemotherapy after curative mastectomy. For elucidating a relationship between CSCs and resistance to chemotherapy, we evaluated primary tumor and metastatic cutaneous lesions by CSC markers in immunohistochemical stains (CD44(+)/CD24(-) and ALDH-1). Either CD44(+)/CD24(-) or ALDH-1 expression increased compared to primary breast cancer during chemotherapy. This case report shows that CD44(+)/CD24(-) or ALDH-1 expression in primary or cutaneous metastatic breast cancer may be associated with rapid onset chemoresistance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。